4zgz
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==STRUCTURE OF HUMAN ANTIZYME INHIBITOR IN COMPLEX WITH A C-TERMINAL FRAGMENT OF ANTIZYME== | ==STRUCTURE OF HUMAN ANTIZYME INHIBITOR IN COMPLEX WITH A C-TERMINAL FRAGMENT OF ANTIZYME== | ||
- | <StructureSection load='4zgz' size='340' side='right' caption='[[4zgz]], [[Resolution|resolution]] 5.81Å' scene=''> | + | <StructureSection load='4zgz' size='340' side='right'caption='[[4zgz]], [[Resolution|resolution]] 5.81Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4zgz]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4zgz]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZGZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZGZ FirstGlance]. <br> |
- | </td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zgz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zgz OCA], [https://pdbe.org/4zgz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zgz RCSB], [https://www.ebi.ac.uk/pdbsum/4zgz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zgz ProSAT]</span></td></tr> |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/AZIN1_HUMAN AZIN1_HUMAN] Antizyme inhibitor protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake by counteracting the negative effect of antizyme OAZ1, OAZ2 and OAZ3 on ODC1 activity (PubMed:17900240). Inhibits antizyme-dependent ODC degradation by binding to antizymes. Releases ODC1 from its inactive complex with antizymes, leading to formation of the catalytically active ODC1.<ref>PMID:17900240</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 17: | ||
</div> | </div> | ||
<div class="pdbe-citations 4zgz" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4zgz" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Antizyme inhibitor 3D structures|Antizyme inhibitor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Chan NL]] |
- | [[Category: | + | [[Category: Chen SF]] |
- | [[Category: | + | [[Category: Wu HY]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 07:27, 18 May 2023
STRUCTURE OF HUMAN ANTIZYME INHIBITOR IN COMPLEX WITH A C-TERMINAL FRAGMENT OF ANTIZYME
|